| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Occupational Health Program, Departments of Environmental Health [W. Z., G. L., D. P. M., L. L. X., L. S., D. C. C.] and Biostatistics [S. W. T.], Harvard School of Public Health, Boston, Massachusetts, 02115, and Hematology-Oncology [G. L., T. J. L.], Pulmonary and Critical Care Unit [D. C. C.], Department of Medicine, and Thoracic Surgery Unit, Department of Surgery [J. C. W.], Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
XRCC1 (X-ray cross-complementing group 1) and ERCC2 (excision repair cross-complementing group 2) are two major DNA repair proteins. Polymorphisms of these two genes have been associated with altered DNA repair capacity and cancer risk. We have described statistically significant interactions between the ERCC2 polymorphisms (Asp312Asn and Lys751Gln) and smoking in lung cancer risk. In this case-control study of 1091 Caucasian lung cancer patients and 1240 controls, we explored the gene-environment interactions between the XRCC1 Arg399Gln polymorphism, alone or in combination with the two ERCC2 polymorphisms, and cumulative smoking exposure in the development of lung cancer. The results were analyzed using logistic regression models, adjusting for relevant covariates. Overall, the adjusted odds ratio (OR) of XRCC1 Arg399Gln polymorphism (Gln/Gln versus Arg/Arg) was 1.3 [95% confidence interval (CI), 1.0–1.8]. Stratified analyses revealed that the ORs decreased as pack-years increased. For nonsmokers, the adjusted OR was 2.4 (95% CI, 1.2–5.0), whereas for heavy smokers (
55 pack-years), the OR decreased to 0.5 (95% CI, 0.3–1.0). When the three polymorphisms were evaluated together, the adjusted ORs of the extreme genotype combinations of variant alleles (individuals with 5 or 6 variant alleles) versus wild genotype (individuals with 0 variant alleles) were 5.2 (95% CI, 1.7–16.6) for nonsmokers and 0.3 (95% CI, 0.1–0.8) for heavy smokers, respectively. Similar gene-smoking interaction associations were found when pack-years of smoking (or smoking duration and smoking intensity) was fitted as a continuous variable. In conclusion, cumulative cigarette smoking plays an important role in altering the direction and magnitude of the associations between the XRCC1 and ERCC2 polymorphisms and lung cancer risk.
This article has been cited by other articles:
|
|
 |
|
  G. Liu, W. Zhou, B. Y. Yeap, L. Su, J. C. Wain, J. M. Poneros, N. S. Nishioka, T. J. Lynch, and D. C. Christiani XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk Carcinogenesis, June 1, 2007; 28(6): 1254 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote The molecular epidemiology of lung cancer Carcinogenesis, March 1, 2007; 28(3): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Hill, S. S. Wang, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, P. Hartge, S. Wacholder, M. Yeager, S. J. Chanock, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes Blood, November 1, 2006; 108(9): 3161 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, A.M. Dunning, S. Guarrera, C. Baynes, S. Polidoro, S. Garte, H. Autrup, C. Malaveille, M. Peluso, L. Airoldi, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study Carcinogenesis, May 1, 2006; 27(5): 997 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Su, W. Zhou, K. Asomaning, X. Lin, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer Carcinogenesis, May 1, 2006; 27(5): 1024 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Andrew, H. H. Nelson, K. T. Kelsey, J. H. Moore, A. C. Meng, D. P. Casella, T. D. Tosteson, A. R. Schned, and M. R. Karagas Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility Carcinogenesis, May 1, 2006; 27(5): 1030 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. de las Penas, M. Sanchez-Ronco, V. Alberola, M. Taron, C. Camps, R. Garcia-Carbonero, B. Massuti, C. Queralt, M. Botia, R. Garcia-Gomez, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients Ann. Onc., April 1, 2006; 17(4): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hung, J. Hall, P. Brennan, and P. Boffetta Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review Am. J. Epidemiol., November 15, 2005; 162(10): 925 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Matullo, S. Guarrera, C. Sacerdote, S. Polidoro, L. Davico, S. Gamberini, M. Karagas, G. Casetta, L. Rolle, A. Piazza, et al. Polymorphisms/Haplotypes in DNA Repair Genes and Smoking: A Bladder Cancer Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, J. D. Sison, K. Aldape, A. McMillan, J. Wiemels, and J. K. Wiencke ERCC1 and ERCC2 polymorphisms and adult glioma Neuro-oncol, October 1, 2005; 7(4): 495 - 507. [Abstract] [PDF]
|
|
|
|
|
|
J. Siemiatycki Synthesizing the Lifetime History of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2294 - 2295. [Full Text] [PDF]
|
|
|
|
|
|
S. W. Thurston, G. Liu, D. P. Miller, and D. C. Christiani Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Huang, W.-H. Chow, N. Rothman, J. Lissowska, V. Llaca, M. Yeager, W. Zatonski, and R. B. Hayes Selected DNA repair polymorphisms and gastric cancer in Poland Carcinogenesis, August 1, 2005; 26(8): 1354 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hu, H. Ma, F. Chen, Q. Wei, and H. Shen XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1810 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Jeon, J. W. Kim, N.-H. Park, Y.-S. Song, S.-B. Kang, and H.-P. Lee DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma Hum. Reprod., June 1, 2005; 20(6): 1586 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hung, P. Brennan, F. Canzian, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, et al. Large-Scale Investigation of Base Excision Repair Genetic Polymorphisms and Lung Cancer Risk in a Multicenter Study J Natl Cancer Inst, April 20, 2005; 97(8): 567 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, M. D. Gammon, M. B. Terry, L. Wang, Q. Wang, F. Zhang, S. L. Teitelbaum, S. M. Eng, S. K. Sagiv, M. M. Gaudet, et al. Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 336 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, S. Park, Z. Wang, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, X. Miao, G. Liang, B. Hao, Y. Wang, W. Tan, Y. Li, Y. Guo, F. He, Q. Wei, et al. Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer Cancer Res., February 1, 2005; 65(3): 722 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benhamou and A. Sarasin ERCC2 /XPD Gene Polymorphisms and Lung Cancer: A HuGE Review Am. J. Epidemiol., January 1, 2005; 161(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Justenhoven, U. Hamann, B. Pesch, V. Harth, S. Rabstein, C. Baisch, C. Vollmert, T. Illig, Y.-D. Ko, T. Bruning, et al. ERCC2 Genotypes and a Corresponding Haplotype Are Linked with Breast Cancer Risk in a German Population Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2059 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-E Wang, M. L. Bondy, H. Shen, R. El-Zein, K. Aldape, Y. Cao, V. Pudavalli, V. A. Levin, W. K. A. Yung, and Q. Wei Polymorphisms of DNA Repair Genes and Risk of Glioma Cancer Res., August 15, 2004; 64(16): 5560 - 5563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Figueiredo, J. A. Knight, L. Briollais, I. L. Andrulis, and H. Ozcelik Polymorphisms XRCC1-R399Q and XRCC3-T241M and the Risk of Breast Cancer at the Ontario Site of the Breast Cancer Family Registry Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology Cancer Res., March 15, 2004; 64(6): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hagmar, U. Stromberg, S. Bonassi, I.-L. Hansteen, L. E. Knudsen, C. Lindholm, and H. Norppa Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk: Results from Nordic and Italian Cohorts Cancer Res., March 15, 2004; 64(6): 2258 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Mohrenweiser Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145. [Abstract] [PDF]
|
|
|
|
|
|
X.-O. Shu, Q. Cai, Y.-T. Gao, W. Wen, F. Jin, and W. Zheng A Population-Based Case-Control Study of the Arg399Gln Polymorphism in DNA Repair Gene XRCC1 and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1462 - 1467. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
